| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 10,764 | 11,493 | 11,803 | 12,822 | | Cost of Revenue | 3,407 | 3,629 | 3,667 | 4,550 | | | Gross Profit |
-
| 7,864 | 8,136 | 8,272 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,797 | 6,846 | 6,831 | 5,034 | | Non Recurring | (756) | 199 | 1,319 | 1,438 | | Others | 610 | 8,600 | 5,158 | 1,937 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (7,781) | (5,172) | (137) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 706 | (7,781) | (5,172) | (137) | | Interest Expense | 501 | 514 | 603 | 714 | | Income Before Tax | 205 | (8,295) | (5,775) | (851) | | Income Tax Expense | 20 | (2,860) | (2,015) | (435) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 185 | (5,435) | (3,760) | (416) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 185 | (5,435) | (3,760) | (416) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $185 | ($5,435) | ($3,760) | ($416) |
|
0.02% Nasdaq 
0.14 (3.30%) 
Income Statement
